Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.10 EUR
9.95 M EUR
3.91 B EUR
48.66 M
About Charles River Laboratories International, Inc.
Sector
CEO
James C. Foster
Website
Headquarters
Wilmington
Founded
1947
ISIN
US1598641074
FIGI
BBG01TNXVW84
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
CRL5145816
Charles River Laboratories International, Inc. 4.0% 15-MAR-2031Yield to maturity
5.44%
Maturity date
Mar 15, 2031
CRL4900987
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
5.30%
Maturity date
May 1, 2028
CRL5145814
Charles River Laboratories International, Inc. 3.75% 15-MAR-2029Yield to maturity
5.14%
Maturity date
Mar 15, 2029
CRL4900988
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
—
Maturity date
May 1, 2028
See all 1CRL bonds
CSH2
Amundi Smart Overnight Return UCITS ETF C-GBP- CapitalisationWeight
0.28%
Market value
35.07 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of 1CRL is 147.15 EUR — it has decreased by −3.79% in the past 24 hours. Watch Charles River Laboratories International, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Charles River Laboratories International, Inc. stocks are traded under the ticker 1CRL.
1CRL stock has risen by 15.82% compared to the previous week, the month change is a 5.60% rise, over the last year Charles River Laboratories International, Inc. has showed a 48.52% increase.
We've gathered analysts' opinions on Charles River Laboratories International, Inc. future price: according to them, 1CRL price has a max estimate of 179.87 EUR and a min estimate of 132.13 EUR. Watch 1CRL chart and read a more detailed Charles River Laboratories International, Inc. stock forecast: see what analysts think of Charles River Laboratories International, Inc. and suggest that you do with its stocks.
1CRL reached its all-time high on Jul 29, 2025 with the price of 155.70 EUR, and its all-time low was 99.10 EUR and was reached on Apr 25, 2025. View more price dynamics on 1CRL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1CRL stock is 3.94% volatile and has beta coefficient of 0.40. Track Charles River Laboratories International, Inc. stock price on the chart and check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
Today Charles River Laboratories International, Inc. has the market capitalization of 7.35 B, it has increased by 12.09% over the last week.
Yes, you can track Charles River Laboratories International, Inc. financials in yearly and quarterly reports right on TradingView.
Charles River Laboratories International, Inc. is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
1CRL earnings for the last quarter are 2.65 EUR per share, whereas the estimation was 2.12 EUR resulting in a 24.69% surprise. The estimated earnings for the next quarter are 2.00 EUR per share. See more details about Charles River Laboratories International, Inc. earnings.
Charles River Laboratories International, Inc. revenue for the last quarter amounts to 876.18 M EUR, despite the estimated figure of 836.38 M EUR. In the next quarter, revenue is expected to reach 841.42 M EUR.
1CRL net income for the last quarter is 44.42 M EUR, while the quarter before that showed 23.54 M EUR of net income which accounts for 88.68% change. Track more Charles River Laboratories International, Inc. financial stats to get the full picture.
No, 1CRL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 8, 2025, the company has 20.1 K employees. See our rating of the largest employees — is Charles River Laboratories International, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Charles River Laboratories International, Inc. EBITDA is 770.62 M EUR, and current EBITDA margin is 22.93%. See more stats in Charles River Laboratories International, Inc. financial statements.
Like other stocks, 1CRL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Charles River Laboratories International, Inc. stock right from TradingView charts — choose your broker and connect to your account.